• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACESSA HEALTH INC. ACESSA; ACESSA PROVU

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACESSA HEALTH INC. ACESSA; ACESSA PROVU Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problem Needle Stick/Puncture (2462)
Event Date 10/29/2020
Event Type  Injury  
Manufacturer Narrative
As described through communication with the acessa representative and physician, at no point during the acessa procedure was it observed that a needle had protruded through the posterior uterine wall and punctured the bladder.As stated, the uterine manipulator, while used during the procedure, was not used while the needles were deployed and ablating.There was no report of malfunction of any component of the provu system, including the handpiece.It is therefore most likely that the injury was the result of misuse and misplacement of the device.The acessa provu system user's guide warns users on several occasions that handpiece placement should be confirmed with ultrasound prior to the activation of rf energy, and that the electrode needle array should be fully retracted before positioning, advancing, or withdrawing the handpiece.The acessa provu system user's guide also acknowledges that damage to adjacent structures is an inherent risk for radiofrequency ablation of fibroids and is a common risk to all surgical procedures for fibroid treatment.However, based on the information provided thus far through investigation, there is nothing to indicate that the injury and subsequent reintervention were the result of a malfunction or deficiency in the manufacturing, design, or labeling of the acessa provu system.Acessa will submit a supplemental report should additional information be made available.
 
Event Description
Acessa representative notified of patient who underwent interventional bladder resection immediately following her acessa procedure on (b)(6) 2020.Patient presented for her acessa case with one singular fundal fibroid ~6 cm.The acessa procedure consisted of 10 total ablations, the majority being anterior, with the last 2-3 directed posterior at an approximate 45 degree angle.A uterine manipulator was utilized by the attending scrub tech.After the last ablation, during clean up, the acessa physician noticed blanching of the posterior uterine wall near the bladder.The bladder was insufflated to confirm bladder injury.Urologist was called in for cystoscopy, though no damage to the bladder interior was observed.The patient then underwent open surgery with the urologist to resect the damaged tissue ~1-1.5 sq.Inches.During the open portion of the procedure, a "pin hole", characteristic of one of the handpiece needles, was observed on the bladder exterior.Following the intervention, the patient was expected to make a full recovery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACESSA
Type of Device
ACESSA PROVU
Manufacturer (Section D)
ACESSA HEALTH INC.
317 grace ln
suite 200
austin TX 78746
Manufacturer (Section G)
ACESSA HEALTH INC.
317 grace ln
suite 200
austin TX 78746
Manufacturer Contact
isaac rodriguez
317 grace ln
suite 200
austin, TX 78746
5127850707
MDR Report Key10906106
MDR Text Key218497862
Report Number3006443171-2020-00004
Device Sequence Number1
Product Code HFG
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K181124
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/29/2020
Initial Date FDA Received11/25/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-